MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression
批准号:
8846055
负责人:
Rafael A. Fridman
金额:
$26.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-06 至 2017-04-30
关键词:
3-DimensionalAddressAdhesivesArchitectureBasement membraneBiochemicalBiological AssayBiological ModelsBreastBreast Cancer CellBreast Cancer ModelBreast Cancer PatientBreast Cancer cell lineBreast CarcinomaBreast Epithelial CellsCancer ControlCancerousCarcinomaCellsCleaved cellCollagenCollagen ReceptorsDDR1 geneDDR2 geneDataDevelopmentDiagnosticDistant MetastasisDown-RegulationEngineeringEnzymesEpithelialEpitheliumExperimental ModelsExtracellular MatrixFamilyFundingHumanIn SituIn VitroInvadedKnowledgeLigandsLightMMP14 geneMT3 geneMaintenanceMalignant - descriptorMalignant NeoplasmsMammary Gland ParenchymaMammary glandMatrix MetalloproteinasesMediatingMediator of activation proteinMembraneMesenchymalModelingMolecularMorphogenesisMusNeoplasm MetastasisOutcomePatientsPhenotypePhosphotransferasesPlayProcessProteolysisReceptor ActivationReceptor Cross-TalkReceptor Protein-Tyrosine KinasesRegulationReportingRoleSignal TransductionStructure-Activity RelationshipSupporting CellSystemTestingTherapeuticTimeTissuesbasebreast cancer diagnosiscancer cellcell behaviorcell motilitycohortdesigndiscoidin receptorhuman MMP14 proteinhuman tissueimprovedin vivoinformation gatheringinsightmalignant breast neoplasmmalignant phenotypemembermembrane-type matrix metalloproteinaseneoplastic cellnovelprogramspublic health relevancereceptorresponsetherapeutic targettumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long term of our studies is to understand the functional contribution of proteolytic
systems to cancer progression. We have focused on the action of membrane type-
matrix metalloproteinases (MT-MMPs) known to promote pro-invasive activity through
tissue barriers, particularly MT1-MMP (MMP14). We now show a novel interaction
between three members of the MT-MMP family, MT1- (MMP14), MT2- (MMP15), and
MT3- (MP16) MP (refered here to as MT-MMPs), and the discoidin domain
receptors (DDRs), a unique set of receptor tyrosine kinases (RTKs) that are specifically
activated in response to collagen, which together with MT-MMPs' collagenolytic activity
may orchestrate the proteolytic and adhesive programs during tumor cell dissemination.
Preliminary data show a unique functional and specific relationship between MT-MMPs
and DDRs that leads to downregulation of collagen-evoked DDR (DDR1 and DDR2)
activation in a process that goes beyond receptor cleavage. Indeed, MT-MMPs
selectively cleave DDR1 but not DDR2. We also report a gradual loss of DDR1
expression in invasive breast carcinomas suggesting a role for DDR1 in the transition
from in situ to invasive carcinoma. Since DDR1 has been implicated in maintenance of
normal mammary epithelial function and DDR2 may be associated with mesenchymal-
like phenotypes, we posit that a differential regulation of DDRs by MT-MMPs may
contribute to the disruption of normal breast tissue architecture and function that leads to
malignant cancer. To test this hypothesis we propose thre Specific Aims: 1) To
investigate the structural bases, molecular mechanisms, and functional consequences of
DDR/MT-MMP interactions, 2) To investigate the expression of DDRs and MT1-MMP in
human breast cancer tissues, and 3) To Investigate the DDR/MT1-MMP interplay in
experimental models of breast epithelial-matrix interactions. The studies in this
application will fill a wide gap of knowledge on our understanding of DDR regulation and
function, and wil shed light on how their interactions with MT-MMPs influence cell
behavior in normal and malignant breast epithelium. We hope that this new knowledge
will help to develop better therapeutic and diagnostic strategies to improve survival in
breast cancer patients.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/978-1-61779-854-2_8
发表时间:
2012-01-01
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
[Toth, Marta, Sohail, Anjum, Fridman, Rafael]
通讯作者:
Fridman, Rafael
DOI:
10.1385/1-59259-136-1:163
发表时间:
2001-01-01
期刊:
Methods in molecular medicine
影响因子:
--
作者:
[Toth, M, Fridman, R]
通讯作者:
Fridman, R
DOI:
--
发表时间:
1999-12
期刊:
Cancer research
影响因子:
11.2
作者:
[Gangyong Li;R. Fridman;Hyeong‐Reh Choi Kim]
通讯作者:
Gangyong Li;R. Fridman;Hyeong‐Reh Choi Kim
DOI:
10.1111/j.1747-0285.2008.00750.x
发表时间:
2009-02
期刊:
Chemical biology & drug design
影响因子:
3
作者:
[Lee M, Celenza G, Boggess B, Blase J, Shi Q, Toth M, Bernardo MM, Wolter WR, Suckow MA, Hesek D, Noll BC, Fridman R, Mobashery S, Chang M]
通讯作者:
Chang M
DOI:
10.1016/j.ejmech.2011.03.033
发表时间:
2011-07
期刊:
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
影响因子:
6.7
作者:
[Nuti, Elisa, Casalini, Francesca, Santamaria, Salvatore, Gabelloni, Pamela, Bendinelli, Sara, Da Pozzo, Eleonora, Costa, Barbara, Marinelli, Luciana, La Pietra, Valeria, Novellino, Ettore, Bernardo, M. Margarida, Fridman, Rafael, Da Settimo, Federico, Martini, Claudia, Rossello, Armando]
通讯作者:
Rossello, Armando
共 15 条
Gordon Research Conference and Gordon-Kenan Research Seminar on Matrix Metallopro
-
批准号:8119866
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2011
-
负责人:Rafael A. Fridman
-
依托单位:
Novel approach for inhibition of MT1-MMP/gelatinase axis
-
批准号:7087070
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Novel approach for inhibition of MT1-MMP/gelatinase axis
-
批准号:6913692
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Novel approach for inhibition of MT1-MMP/gelatinase axis
-
批准号:6600235
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Targeting MT-MMPs in Cancer Progression
-
批准号:7649621
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Targeting MT-MMPs in Cancer Progression
-
批准号:7777309
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Targeting MT-MMPs in Cancer Progression
-
批准号:8213496
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Targeting MT-MMPs in Cancer Progression
-
批准号:8019100
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Targeting MT-MMPs in Cancer Progression
-
批准号:8444682
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
Novel approach for inhibition of MT1-MMP/gelatinase axis
-
批准号:6733535
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2003
-
负责人:Rafael A. Fridman
-
依托单位:
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS
-
批准号:6173604
-
项目类别:
-
资助金额:$24.88万
-
财政年份:1999
-
负责人:Rafael A. Fridman
-
依托单位:
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS
-
批准号:6514058
-
项目类别:
-
资助金额:$26.39万
-
财政年份:1999
-
负责人:Rafael A. Fridman
-
依托单位:
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS
-
批准号:2884072
-
项目类别:
-
资助金额:$21.18万
-
财政年份:1999
-
负责人:Rafael A. Fridman
-
依托单位:
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS
-
批准号:6377324
-
项目类别:
-
资助金额:$25.62万
-
财政年份:1999
-
负责人:Rafael A. Fridman
-
依托单位:
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS
-
批准号:6633450
-
项目类别:
-
资助金额:$27.18万
-
财政年份:1999
-
负责人:Rafael A. Fridman
-
依托单位:
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION
-
批准号:2895083
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1995
-
负责人:Rafael A. Fridman
-
依托单位:
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy
-
批准号:7051208
-
项目类别:
-
资助金额:$26.55万
-
财政年份:1995
-
负责人:Rafael A. Fridman
-
依托单位:
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION
-
批准号:2102905
-
项目类别:
-
资助金额:$18.7万
-
财政年份:1995
-
负责人:Rafael A. Fridman
-
依托单位:
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression
-
批准号:8453475
-
项目类别:
-
资助金额:$24.47万
-
财政年份:1995
-
负责人:Rafael A. Fridman
-
依托单位:
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION
-
批准号:6194308
-
项目类别:
-
资助金额:$25.83万
-
财政年份:1995
-
负责人:Rafael A. Fridman
-
依托单位:
海外基金